ARCHIVES

PDQ Used Mainly For Information To Public, Not Much By Non-Oncologists, Evaluation Finds

This article is from The Cancer Letter archive.

Vol. 15 No. 33 | August 18, 1989

Download PDF Visit The Full Archive

Related Articles

In Brief: Best Guess On NCI Director: Brown First Choice, Benacerraf Second; FDa On Saccharin

April 22, 1977

Intense Therapies Better Than Lower Dose For AML

November 26, 2004

Hammer Blast GAO Report As ”Gobblygook”

June 12, 1987

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

November 26, 2010

ACS Research Grants Hit $78.2 Million

July 18, 1986

NCI Programs: HMO Research Network wins $16 Million Grant for Prevention Studies

July 30, 1999